← Open Payments lookup

LAURA HOSTOVICH: Open Payments

NPI 1588667943 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,510 in 95 payments from 37 companies in 2025. Trend: 2023 $1,517 · 2024 $2,368 · 2025 $2,510

Food & beverage: $2,510
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation15$330
Janssen Biotech, Inc.6$260
AstraZeneca Pharmaceuticals LP7$201
Bayer Healthcare Pharmaceuticals Inc.3$143
Takeda Pharmaceuticals U.S.A., Inc.5$130
PFIZER INC.5$110
Regeneron Healthcare Solutions, Inc.4$98
Daiichi Sankyo Inc.3$81
ABBVIE INC.3$79
SOBI, INC3$68

Products named: RYBREVANT, Nubeqa, VPRIV, PLUVICTO, Enhertu, SCEMBLIX, VENCLEXTA, LYNPARZA.

Industry payments across MD — which companies pay providers there.